Suche
Mein Konto
An arm and a leg”: The new cap on Medicare drug costs
On a Sunday afternoon in August, health researcher Stacie Dusetzina sat alone in her office at Vanderbilt University. Watching C-SPAN and crying. The US Senate voted on the Inflation Reduction Act, which is intended, among other things, to ensure that Medicare recipients pay less for expensive drugs. It's a big business. Many seniors pay $10,000 or more annually for medications or go without life-saving treatments; Once the new law goes into effect, it will set a copayment limit of $2,000 per year. Dusetzina and her colleagues have advocated for this change for years and documented how current policies affect people in...
An arm and a leg”: The new cap on Medicare drug costs
On a Sunday afternoon in August, health researcher Stacie Dusetzina sat alone in her office at Vanderbilt University. Watching C-SPAN and crying.
The US Senate voted on the Inflation Reduction Act, which is intended, among other things, to ensure that Medicare recipients pay less for expensive drugs.
It's a big business. Many seniors pay $10,000 or more annually for medications or go without life-saving treatments; Once the new law goes into effect, it will set a copayment limit of $2,000 per year.
Dusetzina and her colleagues have been advocating for this change for years and documenting how current policies are failing people.
The pharmaceutical industry has fought this change tooth and nail - for decades. Julie Rovner, KHN's chief Washington correspondent, takes listeners back to the late 1980s, when Congress learned the cost of taking on Big Pharma.
“An Arm and a Leg” is a co-production of KHN and Public Road Productions.
To stay in touch with An Arm and a Leg, Subscribe to the newsletter. You can also watch the show on Facebook and Twitter. And if you have stories to tell about the healthcare system, the producers would love to hear from you.
|
|
.